BIOMARKERS OF CARDIOVASCULAR RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

by Petrov I. M., Medvedeva I. V., Sholomov I. F., Chesnokova L. V., Petrova Yu. A., Snezhitskiy V. A., Kalatsei L. V., Gladkevich А. V.
Published 2020-06-01

2019 EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH SUPRAVENTRICULAR TACHYCARDIA: WHAT’S NEW?

by Kalatsei L. V., Snezhitskiy V. A.
Published 2020-05-01

CORONAVIRUS DISEASE (COVID-19) TREATMENT ALGORITHMS IN PATIENTS WITH QT INTERVAL PROLONGATION

by Kalatsei L. V., Snezhitskiy V. A., Ardashev A. V.
Published 2020-05-01

LONG QT SYNDROME. PART 1

by Kalatsei L. V., Snezhitskiy V. A.
Published 2018-09-01

LONG QT SYNDROME. PART 2

by Kalatsei L. V., Snezhitskiy V. A.
Published 2018-11-01

METHODOLOGICAL APPROACHES TO MEASURING AND ESTIMATING THE DURATION OF QT INTERVAL OF A STANDARD ELECTROCARDIOGRAM

by Kalatsei L. V., Snezhitskiy V. A.
Published 2019-03-01